Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · second_quarter · Q2
Advocating against the adverse impact on Medicaid and Medicare patients by the efforts of pharmaceutical manufacturers to impose restrictions on contract pharmacies and impose a rebate reimbursement process
Contract Pharmacy (no bill), Advocating against pharmaceutical manufacturers' efforts to limit 340B covered entities to one contract pharmacy per 40-mile radius Rebate Model (no bill) Advocating against pharmaceutical manufacturers' efforts to switch the 340B program to a rebate model from a discount structure.
Source: Senate LDA
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Client: 340B HEALTH · Firm: RAY ANDERSON
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals 6. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Client: 340B HEALTH · Firm: RAY ANDERSON
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals 6. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Client: 340B HEALTH · Firm: RAY ANDERSON
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Client: 340B HEALTH · Firm: RAY ANDERSON
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Client: 340B HEALTH · Firm: RAY ANDERSON
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals
A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Client: 340B HEALTH · Firm: RAY ANDERSON
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts
340B regulatory policy regarding contract pharmacy 340B regulatory policy regarding a proposed rebate payment model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2026 · first_quarter · Q1
Contract Pharmacy (no bill), Advocating against pharmaceutical manufacturers' efforts to limit 340B covered entities to one contract pharmacy per 40-mile radius Rebate Model (no bill) Advocating against pharmaceutical manufacturers' efforts to switch the 340B program to a rebate model from a discount structure.
Advocating against the adverse impact on Medicaid and Medicare patients by the efforts of pharmaceutical manufacturers to impose restrictions on contract pharmacies
340B regulatory policy regarding contract pharmacy 340B regulatory policy regarding a proposed rebate payment model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2025 · fourth_quarter · Q4
340B regulatory policy regarding contract pharmacy 340B regulatory policy regarding a proposed rebate payment model
Contract Pharmacy (no bill), Advocating against pharmaceutical manufacturers' efforts to limit 340B covered entities to one contract pharmacy per 40-mile radius Rebate Model (no bill) Advocating against pharmaceutical manufacturers' efforts to switch the 340B program to a rebate model from a discount structure.
Advocating against the adverse impact on Medicaid and Medicare patients by the efforts of pharmaceutical manufacturers to impose restrictions on contract pharmacies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2025 · third_quarter · Q3
Advocating against the adverse impact on Medicaid and Medicare patients by the efforts of pharmaceutical manufacturers to impose restrictions on contract pharmacies
340B regulatory policy regarding contract pharmacy 340B regulatory policy regarding a proposed rebate payment model
Contract Pharmacy (no bill), Advocating against pharmaceutical manufacturers' efforts to limit 340B covered entities to one contract pharmacy per 40-mile radius Rebate Model (no bill) Advocating against pharmaceutical manufacturers' efforts to switch the 340B program to a rebate model from a discount structure.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2025 · second_quarter · Q2
340B regulatory policy regarding contract harmacy 340B regulatory policy regarding a proposed rebate payment model
Contract Pharmacy (no bill), Advocating against pharmaceutical manufacturers' efforts to limit 340B covered entities to one contract pharmacy per 40-mile radius Rebate Model (no bill) Advocating against pharmaceutical manufacturers' efforts to switch the 340B program to a rebate model from a discount structure.
Advocating against the adverse impact on Medicaid and Medicare patients by the efforts of pharmaceutical manufacturers to impose restrictions on contract pharmacies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2025 · first_quarter · Q1
340B regulatory policy regarding contract harmacy 340B regulatory policy regarding a proposed rebate payment model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2024 · fourth_quarter · Q4
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2024 · third_quarter · 3A
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2024 · third_quarter · Q3
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program) Letter to HHS Secretary Becerra
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2024 · second_quarter · Q2
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Filing targets: HOUSE OF REPRESENTATIVES
2024 · first_quarter · Q1
Contract Pharmacy-HR 7635, The 340B PATIENTS Act of 2024 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Filing targets: HOUSE OF REPRESENTATIVES
2023 · fourth_quarter · Q4
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Filing targets: HOUSE OF REPRESENTATIVES
2023 · third_quarter · Q3
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
2023 · second_quarter · Q2
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
Contract Pharmacy Protect 340B-340B Patients Act (not yet introduced) 340B Transparency-Opposition to H.R. 3290 (overly burdensome reporting legislation that distorts the 340B program)
2023 · first_quarter · Q1
Contract Pharmacy-No legislation yet 340B Transparency-No legislation yet
Contract Pharmacy-no legislation yet 340B Transparency-no legislation yet
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
2022 · fourth_quarter · Q4
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to contract pharmacies Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate Requested Representative Spanberger and Representative Danny K. Davis and members of the Congressional Black Caucus participation in a Congressional Special Order Hour session. Gathered CBC member signatures on a Dear Colleague request to Secretary of HHS
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2022 · third_quarter · Q3
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to contract pharmacies Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate Requested Representative Spanberger and Representative Danny K. Davis and members of the Congressional Black Caucus participation in a Congressional Special Order Hour session. Gathered CBC member signatures on a Dear Colleague request to Secretary of HHS
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2022 · third_quarter · Q3
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to contract pharmacies Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate Requested Representative Spanberger and Representative Danny K. Davis and members of the Congressional Black Caucus participation in a Congressional Special Order Hour session. Gathered CBC member signatures on a Dear Colleague request to Secretary of HHS
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2022 · second_quarter · Q2
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to eligible hospitals Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate Requested Representative Spanberger and Representative Danny K. Davis and members of the Congressional Black Caucus participation in a Congressional Special Order Hour session. Gathered CBC member signatures on a Dear Colleague request to Secretary of HHS
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals 6. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2022 · first_quarter · Q1
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals 6. Advocated for 340B Congressional Special Order Session through Representative Spanberger and Representative Danny K. Davis
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to eligible hospitals Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate Requested Representative Spanberger and Representative Danny K. Davis and members of the Congressional Black Caucus participation in a Congressional Special Order Hour session.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2021 · fourth_quarter · Q4
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to eligible hospitals Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2021 · third_quarter · Q3
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to eligible hospitals Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts 5. Congressional Black Caucus letter regarding Medicare OPPS reimbursement rate for 340 B Hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2021 · second_quarter · Q2
Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to eligible hospitals
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2021 · first_quarter · Q1
340B Discount Outpatient Prescription Drug Policies: 1. Contract pharmacy restrictions-Congressional letter 2. Rebate reimbursement model-Congressional letter 3. DSH eligibility bills- S.773 4. Medicare Part B cuts
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2020 · fourth_quarter · Q4
340B Prescription Drug Policy Regulatory provision to hold harmless safety-net hospitals in 340B program during Covid-19 pandemic; contract pharmacy regulatory policy letter
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2020 · third_quarter · Q3
Public relations benefits of the 340B Prescription Drug Policy Legislative provision to hold harmless safety-net hospitals in 340B program during Covid-19 pandemic; contract pharmacy regulatory policy letter
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2020 · second_quarter · Q2
Public relations benefits of the 340B Prescription Drug Policy Legislative provision to hold harmless safety-net hospitals in 340B program during Covid-19 pandemic
Filing targets: HOUSE OF REPRESENTATIVES
2020 · first_quarter · Q1
Public relations benefits of the 340B Prescription Drug Policy
Filing targets: HOUSE OF REPRESENTATIVES
2019 · fourth_quarter · Q4
Public relations benefits of the 340B Prescription Drug Policy
Filing targets: HOUSE OF REPRESENTATIVES
2019 · fourth_quarter · RR
340 B Prescription Drug legislative and regulatory Policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)